Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Albemarle (ALB) Competitors

Albemarle logo
$171.78 +0.20 (+0.12%)
Closing price 05/22/2026 03:59 PM Eastern
Extended Trading
$171.94 +0.16 (+0.09%)
As of 05/22/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ALB vs. TSLA, ASIX, CBT, CC, and CE

Should you buy Albemarle stock or one of its competitors? MarketBeat compares Albemarle with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Albemarle include Tesla (TSLA), AdvanSix (ASIX), Cabot (CBT), Chemours (CC), and Celanese (CE).

How does Albemarle compare to Tesla?

Albemarle (NYSE:ALB) and Tesla (NASDAQ:TSLA) are related large-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

92.9% of Albemarle shares are held by institutional investors. Comparatively, 66.2% of Tesla shares are held by institutional investors. 0.4% of Albemarle shares are held by company insiders. Comparatively, 19.9% of Tesla shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Tesla had 250 more articles in the media than Albemarle. MarketBeat recorded 262 mentions for Tesla and 12 mentions for Albemarle. Albemarle's average media sentiment score of 1.06 beat Tesla's score of 0.67 indicating that Albemarle is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tesla
136 Very Positive mention(s)
48 Positive mention(s)
49 Neutral mention(s)
23 Negative mention(s)
6 Very Negative mention(s)
Positive

Tesla has a net margin of 3.95% compared to Albemarle's net margin of -5.00%. Albemarle's return on equity of 5.22% beat Tesla's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-5.00% 5.22% 2.51%
Tesla 3.95%4.89%2.93%

Albemarle has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market. Comparatively, Tesla has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market.

Tesla has higher revenue and earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Tesla, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$5.14B3.94-$510.63M-$3.41N/A
Tesla$94.83B16.87$3.79B$1.09390.83

Albemarle presently has a consensus target price of $200.26, suggesting a potential upside of 16.58%. Tesla has a consensus target price of $395.20, suggesting a potential downside of 7.23%. Given Albemarle's stronger consensus rating and higher possible upside, equities research analysts clearly believe Albemarle is more favorable than Tesla.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
1 Sell rating(s)
11 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.54
Tesla
5 Sell rating(s)
17 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.34

Summary

Tesla beats Albemarle on 11 of the 17 factors compared between the two stocks.

How does Albemarle compare to AdvanSix?

AdvanSix (NYSE:ASIX) and Albemarle (NYSE:ALB) are both basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, Albemarle had 11 more articles in the media than AdvanSix. MarketBeat recorded 12 mentions for Albemarle and 1 mentions for AdvanSix. Albemarle's average media sentiment score of 1.06 beat AdvanSix's score of -0.10 indicating that Albemarle is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AdvanSix
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Albemarle
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

86.4% of AdvanSix shares are held by institutional investors. Comparatively, 92.9% of Albemarle shares are held by institutional investors. 5.0% of AdvanSix shares are held by insiders. Comparatively, 0.4% of Albemarle shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AdvanSix presently has a consensus price target of $22.50, indicating a potential upside of 0.99%. Albemarle has a consensus price target of $200.26, indicating a potential upside of 16.58%. Given Albemarle's stronger consensus rating and higher probable upside, analysts plainly believe Albemarle is more favorable than AdvanSix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdvanSix
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Albemarle
1 Sell rating(s)
11 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.54

AdvanSix has a net margin of 0.67% compared to Albemarle's net margin of -5.00%. Albemarle's return on equity of 5.22% beat AdvanSix's return on equity.

Company Net Margins Return on Equity Return on Assets
AdvanSix0.67% 2.18% 1.05%
Albemarle -5.00%5.22%2.51%

AdvanSix has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market. Comparatively, Albemarle has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market.

AdvanSix has higher earnings, but lower revenue than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AdvanSix$1.52B0.39$49.29M$0.3760.21
Albemarle$5.14B3.94-$510.63M-$3.41N/A

AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.9%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.9%. AdvanSix pays out 173.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Albemarle pays out -47.5% of its earnings in the form of a dividend. AdvanSix has raised its dividend for 2 consecutive years and Albemarle has raised its dividend for 30 consecutive years.

Summary

Albemarle beats AdvanSix on 14 of the 20 factors compared between the two stocks.

How does Albemarle compare to Cabot?

Albemarle (NYSE:ALB) and Cabot (NYSE:CBT) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 93.2% of Cabot shares are owned by institutional investors. 0.4% of Albemarle shares are owned by insiders. Comparatively, 3.1% of Cabot shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Cabot has a net margin of 7.97% compared to Albemarle's net margin of -5.00%. Cabot's return on equity of 21.33% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-5.00% 5.22% 2.51%
Cabot 7.97%21.33%9.48%

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.9%. Cabot pays an annual dividend of $1.80 per share and has a dividend yield of 2.2%. Albemarle pays out -47.5% of its earnings in the form of a dividend. Cabot pays out 34.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years and Cabot has increased its dividend for 14 consecutive years.

Albemarle currently has a consensus price target of $200.26, suggesting a potential upside of 16.58%. Cabot has a consensus price target of $80.25, suggesting a potential downside of 3.80%. Given Albemarle's stronger consensus rating and higher possible upside, equities research analysts plainly believe Albemarle is more favorable than Cabot.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
1 Sell rating(s)
11 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.54
Cabot
1 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Albemarle had 11 more articles in the media than Cabot. MarketBeat recorded 12 mentions for Albemarle and 1 mentions for Cabot. Cabot's average media sentiment score of 1.17 beat Albemarle's score of 1.06 indicating that Cabot is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cabot
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Albemarle has a beta of 1.36, indicating that its stock price is 36% more volatile than the broader market. Comparatively, Cabot has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Cabot has lower revenue, but higher earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$5.14B3.94-$510.63M-$3.41N/A
Cabot$3.71B1.16$331M$5.2915.77

Summary

Albemarle and Cabot tied by winning 10 of the 20 factors compared between the two stocks.

How does Albemarle compare to Chemours?

Chemours (NYSE:CC) and Albemarle (NYSE:ALB) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, Chemours had 5 more articles in the media than Albemarle. MarketBeat recorded 17 mentions for Chemours and 12 mentions for Albemarle. Albemarle's average media sentiment score of 1.06 beat Chemours' score of -0.33 indicating that Albemarle is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemours
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Albemarle
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Chemours has higher revenue and earnings than Albemarle. Albemarle is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemours$5.81B0.55-$386M-$2.64N/A
Albemarle$5.14B3.94-$510.63M-$3.41N/A

Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 1.6%. Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.9%. Chemours pays out -13.3% of its earnings in the form of a dividend. Albemarle pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years.

Chemours presently has a consensus target price of $23.55, indicating a potential upside of 10.15%. Albemarle has a consensus target price of $200.26, indicating a potential upside of 16.58%. Given Albemarle's stronger consensus rating and higher possible upside, analysts clearly believe Albemarle is more favorable than Chemours.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Albemarle
1 Sell rating(s)
11 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.54

76.3% of Chemours shares are held by institutional investors. Comparatively, 92.9% of Albemarle shares are held by institutional investors. 0.9% of Chemours shares are held by company insiders. Comparatively, 0.4% of Albemarle shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Chemours has a beta of 1.47, suggesting that its share price is 47% more volatile than the broader market. Comparatively, Albemarle has a beta of 1.36, suggesting that its share price is 36% more volatile than the broader market.

Albemarle has a net margin of -5.00% compared to Chemours' net margin of -6.82%. Chemours' return on equity of 52.49% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemours-6.82% 52.49% 1.78%
Albemarle -5.00%5.22%2.51%

Summary

Albemarle beats Chemours on 11 of the 20 factors compared between the two stocks.

How does Albemarle compare to Celanese?

Albemarle (NYSE:ALB) and Celanese (NYSE:CE) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, dividends, analyst recommendations, institutional ownership, valuation and profitability.

Albemarle has higher earnings, but lower revenue than Celanese. Albemarle is trading at a lower price-to-earnings ratio than Celanese, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$5.14B3.94-$510.63M-$3.41N/A
Celanese$9.54B0.60-$1.17B-$10.01N/A

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 0.9%. Celanese pays an annual dividend of $0.12 per share and has a dividend yield of 0.2%. Albemarle pays out -47.5% of its earnings in the form of a dividend. Celanese pays out -1.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 98.9% of Celanese shares are owned by institutional investors. 0.4% of Albemarle shares are owned by insiders. Comparatively, 0.3% of Celanese shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Albemarle has a net margin of -5.00% compared to Celanese's net margin of -11.54%. Celanese's return on equity of 9.92% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-5.00% 5.22% 2.51%
Celanese -11.54%9.92%2.12%

In the previous week, Albemarle had 7 more articles in the media than Celanese. MarketBeat recorded 12 mentions for Albemarle and 5 mentions for Celanese. Albemarle's average media sentiment score of 1.06 beat Celanese's score of 0.37 indicating that Albemarle is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
8 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Celanese
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Albemarle has a beta of 1.36, meaning that its stock price is 36% more volatile than the broader market. Comparatively, Celanese has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

Albemarle presently has a consensus price target of $200.26, indicating a potential upside of 16.58%. Celanese has a consensus price target of $67.81, indicating a potential upside of 29.42%. Given Celanese's higher possible upside, analysts clearly believe Celanese is more favorable than Albemarle.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
1 Sell rating(s)
11 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.54
Celanese
1 Sell rating(s)
7 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Albemarle beats Celanese on 15 of the 20 factors compared between the two stocks.

Get Albemarle News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALB vs. The Competition

MetricAlbemarleCHEM IndustryMaterials SectorNYSE Exchange
Market Cap$20.24B$13.59B$4.81B$23.18B
Dividend Yield0.94%2.31%5.01%4.10%
P/E Ratio-50.3837.6423.1030.65
Price / Sales3.941.826,749.6614.66
Price / Cash27.0312.2127.2125.12
Price / Book2.571.986.724.74
Net Income-$510.63M$178.05M$157.11M$1.07B
7 Day Performance-2.27%-0.78%-0.51%1.45%
1 Month Performance-8.68%1.78%-0.41%1.58%
1 Year Performance198.03%40.28%74.77%28.44%

Albemarle Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALB
Albemarle
4.4144 of 5 stars
$171.78
+0.1%
$200.26
+16.6%
+198.0%$20.24B$5.14BN/A7,800
TSLA
Tesla
3.1408 of 5 stars
$409.99
-2.9%
$395.20
-3.6%
+25.5%$1.54T$97.88B376.14134,785
ASIX
AdvanSix
2.0037 of 5 stars
$21.77
+0.7%
$25.67
+17.9%
-3.4%$587.03M$1.52B58.851,410
CBT
Cabot
3.4269 of 5 stars
$81.75
+0.9%
$80.25
-1.8%
+12.6%$4.22B$3.71B15.454,100
CC
Chemours
3.6453 of 5 stars
$22.91
-0.9%
$23.09
+0.8%
+107.6%$3.45B$5.81BN/A5,700

Related Companies and Tools


This page (NYSE:ALB) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners